Deltex Medical Group plc (LON:DEMG), the global leader in oesophageal Doppler monitoring (“ODM”) today announced its results for the six-month period ended 30 June 2017. Statutory results · Revenue up..
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), announced today that it will be hosting an investor event on 11 September 2017 following the publication..
Deltex Medical Group plc LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), today announced an update on trading in the half year ended 30 June 2017. Highlights · Overall..
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), has today announced to the markets the publication of a new trial showing excellent results from using..
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), has today announced that it has been granted a new patent. Deltex Medical has been granted patent..
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), has today announced the launch of its first ODM system designed specifically for veterinary use which has..
Deltex Medical Group plc (LON:DEMG) Chief Executive Officer Ewan Phillips caught up with DirectorsTalk for an exclusive interview to discuss the highlights of their results for the year-ended 31 December..
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), announces the launch of non-invasive High Definition Impedance Cardiography (HD-ICG) in the UK, as an additional module..
Deltex Medical Group Plc (LON:DEMG) CEO Ewan Phillips talks to DirectorsTalk about its results for the year ended 31st Dec 2016 and also the award of a grant under the..
Deltex Medical Group plc (LON:DEMG) Chief Executive Officer Ewan Phillips caught up with DirectorsTalk for an exclusive interview to discuss the £200,000 monitor order, the US being a key market,..
Deltex Medical Group Plc (LON:DEMG) CEO Ewan Phillips talks to DirectorsTalk about its new monitor sales in the US and UK. Ewan explains how the orders came about, the focus..
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), has today announced that it has received confirmation of monitor orders worth over £0.2m which, as indicated..
Deltex Medical Group plc (LON:DEMG) Chief Executive Officer Ewan Phillips caught up with DirectorsTalk for an exclusive interview to discuss the increased range of medical conditions for which South Korea..
Deltex Medical Group Plc (LON:DEMG) CEO Ewan Phillips talks to DirectorsTalk about the benefits of the South Korean health authorities decision to increase the range of medical conditions for which..
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), has today announced that the health authorities in South Korea have decided to increase the range of..
Deltex Medical Group plc (LON:DEMG) Chief Financial Officer Jonathan Shaw caught up with DirectorsTalk for an exclusive interview to discuss their latest trading update & platform account RNS released today..
Deltex Medical Group plc (LON:DEMG), the global leader in oesophageal Doppler monitoring (“ODM”), today announces an update on its trading performance for the year ended 31 December 2016. Highlights Group..
